NSCLC (Non-small Cell Lung Carcinoma) Active Not Recruiting Phase 1 / 2 Trials for Durvalumab (DB11714)

IndicationStatusPhase
DBCOND0103105 (NSCLC (Non-small Cell Lung Carcinoma))Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs